Arrowhead Research Corporation Acquires Alvos Therapeutics and Proprietary Library of Targeting Peptides
0 RepliesPASADENA, Calif. - April 11, 2012 - Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in RNA therapeutics and obesity, today announced that it has acquired Alvos Therapeutics, Inc. (formerly known as Mercator Therapeutics, Inc.), a privately-held company that licensed a large platform of proprietary human-derived homing...
Contine Reading & Discuss→
